TFF1 antibody (C-Term)
Quick Overview for TFF1 antibody (C-Term) (ABIN6294638)
Target
See all TFF1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purpose
- Mouse anti-Human TFF1 Antibody [Sodium Azide Free]
-
Specificity
- Cytoplasmic
-
Purification
- A C-terminus peptide was used as the immunogen for the TFF1 antibody.
-
Immunogen
- A C-terminus peptide was used as the immunogen for the TFF1 antibody.
-
-
-
-
Application Notes
-
Immunofluorescence: 0.5-1 μg/mL
Immunohistochemistry (FFPE): 1-2 μg/mL for 30 min at RT (1)
Prediluted format: incubate for 30 min at RT (2) -
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- TFF1 (Trefoil Factor 1 (TFF1))
-
Alternative Name
- Trefoil factor 1
-
Background
-
Target Description: TFF1/Breast cancer estrogen inducible protein pS2 is a trefoil peptide. Trefoil peptides are protease resistant molecules secreted throughout the gut that play a role in mucosal healing. These peptides contain three intra-chain disulfide bonds, forming the trefoil motif, or P-domain. TFF1/pS2 is known to form dimers and this dimerization is thought to play a role in its protective and healing properties. About 60 % of breast carcinomas are positive for pS2. Staining is cytoplasmic, often with localization to the Golgi apparatus. TFF1 is shown to be localized in normal stomach mucosa, gastric fluid, goblet cells in the colon and small intestine, and in ulcerations of the gastrointestinal tract.
Gene Symbol: TFF1///BCEI///PS2
-
Gene ID
- 7031
-
UniProt
- P04155
-
Pathways
- EGFR Signaling Pathway
Target
-